You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Merck
McKesson
Mallinckrodt
Johnson and Johnson
Medtronic
Boehringer Ingelheim

Last Updated: May 27, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for L-Cysteine


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

What is the drug development status for L-Cysteine?

L-Cysteine is an investigational drug.

There have been 16 clinical trials for L-Cysteine. The most recent clinical trial was a Phase 1 trial, which was initiated on October 1st 2018.

The most common disease conditions in clinical trials are Schizophrenia, Lymphoma, B-Cell, and Squamous Cell Carcinoma of Head and Neck. The leading clinical trial sponsors are Peking University People's Hospital, National Cancer Institute (NCI), and American Thoracic Society.

There are one hundred and eighty-five US patents protecting this investigational drug and two international patents.

Recent Clinical Trials for L-Cysteine
TitleSponsorPhase
Effect of N-Acetyl Cysteine (NAC) on the Oral MicrobiomeWake Forest University Health SciencesPhase 2
Risk Stratification-directed NAC for Prevention of Poor Hematopoietic ReconstitutionPeking University People's HospitalPhase 3
Effect of NAC on the Hematopoietic Reconstitution After Haploidentical Hematopoietic Stem Cell TransplantationPeking University People's HospitalPhase 2

See all L-Cysteine clinical trials

Clinical Trial Summary for L-Cysteine

Top disease conditions for L-Cysteine
Top clinical trial sponsors for L-Cysteine

See all L-Cysteine clinical trials

US Patents for L-Cysteine

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
L-Cysteine   Start Trial Benzoylphenyl pyridinylthiazolidine compounds as platelet activating antagonists Abbott Laboratories (Abbott Park, IL)   Start Trial
L-Cysteine   Start Trial Methods of treating Parkinson's disease using melanin   Start Trial
L-Cysteine   Start Trial Inhibitors of farnesyl protein transferase Merck & Co., Inc. (Rahway, NJ)   Start Trial
L-Cysteine   Start Trial Diamino acid derivatives as antihypertensives Schering Corporation (Kenilworth, NJ)   Start Trial
L-Cysteine   Start Trial Peptide analog type-B CCK receptor ligands Abbott Laboratories (Abbott Park, IL)   Start Trial
L-Cysteine   Start Trial Inhibitors of farnesyl protein transferase Merck & Co., Inc. (Rahway, NJ)   Start Trial
L-Cysteine   Start Trial S-nitrosothiols as smooth muscle relaxants and therapeutic uses thereof Brigham and Women's Hospital (Boston, MA)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for L-Cysteine

Drugname Country Document Number Estimated Expiration Related US Patent
L-Cysteine Ireland 920715 2011-03-29   Start Trial
L-Cysteine Portugal 100314 2011-03-29   Start Trial
L-Cysteine World Intellectual Property Organization (WIPO) 9217476 2011-03-29   Start Trial
L-Cysteine Austria 155038 2008-09-13   Start Trial
L-Cysteine Austria 176400 2008-09-13   Start Trial
L-Cysteine Australia 4327089 2008-09-13   Start Trial
L-Cysteine Australia 633517 2008-09-13   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Harvard Business School
Dow
Mallinckrodt
Merck
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.